

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | EUK-134 is a synthetic superoxide dismutase and catalase mimetic. EUK-134 produced a significant reduction in renal dysfunction and injury caused by I/R(ischemia/reperfusion). EUK-134 significantly reduced renal injury caused by oxidative stress in vivo (reduction in PAR formation), and in vitro EUK-134 reduced PTC injury and death caused by H2O2. In vitro, EUK-134 significantly reduced NO (nitric oxide) production by PTCs (proximal tubular cell) incubated with IFN-gamma/LPS(lipopolysaccharide)[3]. Pretreatment with EUK-134 (10 μM) was effective in the prevention of hypertrophic changes in H9C2 cells, reduction of oxidative stress, and prevention of metabolic shift. EUK-134 treatment improved the oxidative status of mitochondria and reversed hypertrophy-induced reduction of mitochondrial membrane potential[4]. After a 75-min left renal artery clamping, a single intravenous injection of EUK-134 at 0.2 mg/kg, just before unclamping, provided significantly better renal function recovery during the week after the ischemic insult compared with recovery of untreated animals[5].In addition, the EUK-8 and EUK-134 improved NASH (Nonalcoholic steatohepatitis) athological features in liver of MCD(methionine/choline-deficient )-fed rats[6]. |
| Concentration | Treated Time | Description | References | |
| IB3-1 cells | 50 μg ml–1 | 18 hours | EUK-134 enhanced the membrane stability of ΔF508-CFTR and maintained its function | Autophagy. 2012 Nov;8(11):1657-72. |
| CFBE41o- cells | 50 μg ml–1 | 18 hours | EUK-134 stabilized ΔF508-CFTR at the plasma membrane and maintained its function | Autophagy. 2012 Nov;8(11):1657-72. |
| HUVECs | 1 μM | 2-hour pretreatment | EUK-134 pretreatment attenuated the H2O2-, Ang II-, and ox-LDL-induced SREBP2 and miR-92a levels | Circulation. 2015 Mar 3;131(9):805-14. |
| ΔCytochrome b 143B cells | 10 μM | 30 minutes or 60 minutes | EUK-134 inhibited the hypoxic activation of AMPK in ΔCytochrome b cells, indicating that ROS is the key signaling molecule for AMPK activation. | Free Radic Biol Med. 2009 May 15;46(10):1386-91. |
| Wild-type mouse embryonic fibroblasts (MEFs) | 10 μM | 30 minutes or 60 minutes | EUK-134 abolished the hypoxic activation of AMPK, indicating that hypoxic activation of AMPK is dependent on ROS. | Free Radic Biol Med. 2009 May 15;46(10):1386-91. |
| MLE-12 cells | 20 μM | 24 hours | EUK-134 completely blocked asbestos- and H2O2-induced mtDNA damage and apoptosis. | Free Radic Biol Med. 2016 Dec;101:482-490. |
| Human Tenon’s fibroblasts (HTFs) | 25 μM | 24 h | EUK-134 significantly inhibited TGFβ1-induced cell proliferation | Antioxidants (Basel). 2020 Nov 13;9(11):1126. |
| Human Tenon’s fibroblasts (HTFs) | 25 μM | 6 h | EUK-134 significantly inhibited TGFβ1-induced H2O2 generation and collagen synthesis | Antioxidants (Basel). 2020 Nov 13;9(11):1126. |
| Primary rat alveolar type II cells | 20 μM | Prevented PM-induced decrease in Na,K-ATPase activity | Am J Respir Cell Mol Biol. 2006 Jun;34(6):670-6. | |
| A549 cells | 5 μM | 24 hours | Prevented PM-induced decrease in Na,K-ATPase membrane protein abundance | Am J Respir Cell Mol Biol. 2006 Jun;34(6):670-6. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | ΔF508-CFTR mutant mice | In vitro culture | 50 μg/ml | 18 hours | EUK-134 stabilized ΔF508-CFTR expression at the airway surface by restoring autophagy and reduced inflammatory markers | Autophagy. 2012 Nov;8(11):1657-72. |
| Mice | Inhalation co-exposure model | Intraperitoneal injection | 10 mg/kg | Single injection, lasting until 24 hours post-exposure | EUK-134 significantly blunted lung inflammation and respiratory function decline confirming the role of oxidant imbalance. | Redox Biol. 2021 Oct;46:102092 |
| Mice | Formalin-induced inflammatory pain model | Intraperitoneal injection | 25 mg/kg | Single injection, observed for 1 hour | EUK-134 significantly reduced formalin-induced inflammatory pain responses, but the analgesic effects of EUK-134 and N2O were not additive. This suggests that reduced ROS levels led to decreased inflammation, but without the presence of ROS, N2O was not able to provide additional analgesia. | J Physiol. 2011 Jan 1;589(Pt 1):135-48 |
| Mice (C57BL/6) | Radiation-induced pneumopathy model | Intraperitoneal injection | 10 μg/g body weight | Three times a week for 3 weeks | To investigate the protective effect of EUK-134 on radiation-induced endothelial cell loss. Results showed that EUK-134 treatment restored the radiation-induced reduction of VE-Cad expression levels and reduced lung fibrosis development. | Antioxid Redox Signal. 2017 Apr 10;26(11):563-582 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.40mL 0.48mL 0.24mL |
12.00mL 2.40mL 1.20mL |
24.00mL 4.80mL 2.40mL |
|
| CAS号 | 81065-76-1 |
| 分子式 | C18H18ClMnN2O4 |
| 分子量 | 416.74 |
| SMILES Code | [Cl-][Mn+3]123[N](CC[N]1=CC4=CC=CC(OC)=C4[O-]2)=CC5=C([O-]3)C(OC)=CC=C5 |
| MDL No. | MFCD08059577 |
| 别名 | |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
H2O: 10 mg/mL(24 mM),配合低频超声,并水浴加热至45℃助溶 |
沪公网安备 31011702889066号
沪ICP备2024050318号-1